Skip to content

PUMP-IT RCT

Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy for initially unresectable colorectal liver metastases: a randomised controlled trial - PUMP-IT RCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56934
Enrollment
306
Registered
2024-03-26
Start date
2024-11-22
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

'Colorectal liver metastases' 'Liver Neoplasms / Surgery' 'Infusion pumps' 'Infusions, intra-arterial' Colon cancer with liver metastases

Interventions

Patients in the intervention arm will first undergo surgery for pump placement and resection of the primary tumour. Subsequently, these patients receive induction therapy with FUDR-HAIP combined wit

Sponsors

Antoni van Leeuwenhoek (AVL)
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: • Unresectable CRLM (as assessed by liver expert panel) • Resectable primary tumour without indication for neoadjuvant treatment • No previous systemic therapy for colorectal cancer • No extrahepatic metastases • Suitable arterial anatomy for pump placement • Written informed consent

Exclusion criteria

Exclusion criteria: • DPD-deficiency • MMR-deficiency

Design outcomes

Primary

MeasureTime frame
overall survival (OS).

Secondary

MeasureTime frame
progression-free survival (PFS), conversion-to-resection rate, R0/R1 resection rate, hepatic progression-free survival (hPFS), radiological response, pathological response, complication rates for pump placement, surgery for the primary tumour and conversion surgery, toxicity of HAIP and systemic therapy, quality of life and cost effectiveness.

Countries

Netherlands

Contacts

Public ContactI P E Tielbeek

Antoni van Leeuwenhoek (AVL)

pump@nki.nl0205129111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 22, 2026